fbpx

Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.

Click the orange button to the right to learn more about what you can start doing today.

Chemo-Brain- Almost Half of Myeloma Patients

Share Button

49 percent experienced worse cog­ni­tive function (chemo-brain) after trans­planta­tion compared to before trans­planta­tion

According to the NCI, in 2015 there were an estimated 124,733 people living with multiple myeloma in the United States. According to the Myeloma Beacon article linked and excerpted below, almost half of those MM survivors are living with some degree of cognitive dysfunction aka chemo-brain.

Related image

After careful reading, you can see the article below focusing on several central issues to our lives as MMers. These issues are central to what newly diagnosed MMers  must consider before undergoing induction therapy and again if he/she is considering an autologous stem cell transplant (ASCT).

Newly diagnosed MMers can take the info below into account when considering your therapy plan.

The central issues for brain health for newly diagnosed MMers are:

  • The more chemotherapy a MMer undergoes, the worse the chemo-brain- from how many cycles of induction therapy to whether or not you have high-dose chemotherapy with autologous stem cell rescue.
  • The older the patient the more likely he/she is to develop chemo-brain
  • Chemo-brain is not a zero-sum side effect- it is not “you have it or you don’t-” 75% of patients suffer from some form of chemo-brain after toxic therapies-

The take-away for the article is 1) can newly diagnosed MMer prevent chemo-brain and 2) can MMers heal our chemo-brain? I believe in those integrative therapies shown to reduce chemo toxicity. Further, I follow chemo-brain healing regimen daily, weekly and monthly. 

I have lived with multiple myeloma since my original diagnosis in 1994. I have lived in complete remission since April of 1999. If you would like to learn more about healing your chemo-brain and/or managing your multiple myeloma, scroll down the page, post a question or a comment and I will reply ASAP.

Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.

Click here to follow along with the Introduction Guide

Click here to get your FREE First Questions Guide

Thank you,

David Emerson

  • MM Survivor
  • MM Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:


“Chemo Brain” May Affect Half Of Myeloma Patients After Initial Therapy, And Is Worsened By Stem Cell Transplantation

Results from a recent study indicate that many myeloma patients are like­ly to suffer im­paired cog­ni­tive func­tion after their initial multiple mye­lo­ma therapy, and stem cell trans­planta­tion often causes further im­pairment.

Nearly half of the patients in the study had cog­ni­tive im­pair­ment, often referred to as ‘chemo-brain,’ after receiving initial anti-myeloma therapy.  Half of the patients experienced further im­pair­ment of cog­ni­tive function at one month and again at three months following autologous (own) stem cell trans­planta­tion.

The study authors explain that the most common signs of cog­ni­tive im­pair­ment were problems with learn­ing, memory, and coordination.

In addition, they note that older patients, minorities, those with more advanced disease, more induction cycles, or impaired cog­ni­tive function following induction therapy were at greater risk for further cog­ni­tive im­pair­ment following stem cell trans­planta­tion...

Based on their results, the investigators suggest that patients who undergo autologous stem cell trans­planta­tion, particularly those who expect to resume work that involves high cog­ni­tive demand, be made aware of the risk of cog­ni­tive im­pair­ment following trans­planta­tion and offered counseling or support…

Results

Following induction therapy and prior to autologous stem cell trans­planta­tion, 47 percent of the patients al­ready showed signs of cog­ni­tive im­pair­ment, with learning/​memory and executive function being the most com­pro­mised. Executive function refers to the ability to plan, organize, strategize, execute, and manage time.

In particular, older patients were found to be more likely to have psycho­motor speed issues. Psycho­motor function refers to simple actions that involve communication between the brain and other body parts, such as throwing a ball or driving a car…

Of the 41 patients who were available to be assessed one month following trans­planta­tion, 49 percent experienced worse cog­ni­tive function after trans­planta­tion compared to before trans­planta­tion. Specifically, 20 percent of patients declined on one, 10 percent on two, and 20 percent on three measures of cog­ni­tive function.

The investigators note that the most common cog­ni­tive issues a month after trans­planta­tion were learning/​memory problems (22 percent to 29 percent of the patients) and motor function (15 percent of the patients).

Of the 29 patients who were available to be assessed three months following trans­planta­tion, 48 percent showed cog­ni­tive decline compared to their cog­ni­tive function one month after trans­planta­tion. Specifically, 31 percent of the patients declined on one, 14 percent on two, and 4 percent on three measures of cog­ni­tive function.

Similar to the previous two assessments, learning/memory problems (18 percent of the patients) and psy­chomotor speed (21 percent of the patients) were the most commonly affected functions.

Age, education, disease stage, number of induction cycles, and cog­ni­tive im­pair­ment prior to stem cell trans­planta­tion were all associated with impaired cog­ni­tive function three months after trans­planta­tion.

The researchers note that only 25 percent of patients displayed stable or improving performance on all cog­ni­tive measures throughout the study.

For more information, please refer to the study in the journal Cancer (abstract).”

 

 

Leave a Comment:

10 comments
Add Your Reply